Safety and immunogenicity of novel group A streptococcal peptide vaccines targeting cryptic epitopes (J8-K4S2 and P*17-K4S2): a first-in-human, double-blinded, phase 1 randomised controlled trial
Vanessa Meier‐Stephenson, Manisha Pandey, Simone Reynolds, Victoria Ozberk et autres